Compare BKH & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKH | INSP |
|---|---|---|
| Founded | 1941 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | N/A | 2018 |
| Metric | BKH | INSP |
|---|---|---|
| Price | $71.55 | $132.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $71.00 | ★ $132.27 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 02-04-2026 | 11-03-2025 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | 7.21 | ★ 34.77 |
| EPS | ★ 3.95 | 1.48 |
| Revenue | ★ $2,271,600,000.00 | $882,622,000.00 |
| Revenue This Year | $10.35 | $14.97 |
| Revenue Next Year | $3.07 | $11.81 |
| P/E Ratio | ★ $18.40 | $88.53 |
| Revenue Growth | 7.04 | ★ 16.81 |
| 52 Week Low | $54.92 | $70.77 |
| 52 Week High | $74.02 | $216.01 |
| Indicator | BKH | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 58.41 | 64.02 |
| Support Level | $69.40 | $129.85 |
| Resistance Level | $73.09 | $147.03 |
| Average True Range (ATR) | 1.28 | 7.90 |
| MACD | -0.21 | -0.57 |
| Stochastic Oscillator | 50.05 | 44.18 |
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.